Key result
This narrative review summarizes the etiopathogenesis, epidemiology, clinical manifestations, diagnosis, prognosis, and treatment of myocarditis related to COVID-19 and mRNA vaccines.
Why the study?
The epidemiology and prognosis of myocarditis related to COVID-19 are unknown, and the risk of myocarditis secondary to vaccination requires consideration in the context of global vaccine benefits.
Design
Narrative review
Authors
Loading...
Synthesizes current knowledge on COVID-19 and mRNA vaccine myocarditis for clinical context; leaves open need for prospective outcome studies.
This narrative review summarizes the etiopathogenesis, epidemiology, clinical manifestations, diagnosis, prognosis, and treatment of myocarditis related to COVID-19 and mRNA vaccines.
Molina-Ramos et al. (2022) conducted a review in Myocarditis related to COVID-19 and SARS-CoV-2 vaccination. COVID-19 infection and SARS-CoV-2 mRNA vaccines was evaluated. This narrative review summarizes the etiopathogenesis, epidemiology, clinical manifestations, diagnosis, prognosis, and treatment of myocarditis related to COVID-19 and mRNA vaccines.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: